Jump to main content
Jump to site search


Hyaluronic acid/PEGylated amphiphilic nanoparticles for pursuit of selective intracellular doxorubicin release

Author affiliations

Abstract

Polyethylene glycol (PEG)-lyted cationic amphiphilic copolymers were employed as complexing agents with biocompatible anionic hyaluronic acid (HA) for the controlled release of doxorubicin (DOX). The overexpressed receptors to HA in a variety of cancerous cells enable preferential endocytosis of the HA-functionalized nanoparticles. Moreover, introduction of HA is supposed to diminish the unfavorable non-specific reactions in the biological milieu. Particularly, the drastic positive charge was validated post-endocytosis as a consequence of our strategic molecular design for the promotion of positive charges of cationic components. This deshielding effect of the anionic hyaluronic acid by endogenous hyaluronidase in endosomes and demotion of PEG at the endosome acid microenvironment consequently results in the structural rearrangement and favorable reaction of the resulting positive-charged structure with the intracellular species and structures, ultimately giving rise to liberation of the doxorubicin for the subsequent molecular pharmaceutic consequences. Simultaneously, the system containing quaternary ammonium salt and hydrophobic n-octyl acrylate (OA) possesses considerable antibacterial ability to alleviate anti-cancer drugs resistance. This delivery system is intended to overcome the intratumor bacteria-induced tumor resistance.

Graphical abstract: Hyaluronic acid/PEGylated amphiphilic nanoparticles for pursuit of selective intracellular doxorubicin release

Back to tab navigation

Supplementary files

Publication details

The article was received on 08 Sep 2018, accepted on 18 Nov 2018 and first published on 20 Nov 2018


Article type: Paper
DOI: 10.1039/C8TB02370K
Citation: J. Mater. Chem. B, 2019, Advance Article
  •   Request permissions

    Hyaluronic acid/PEGylated amphiphilic nanoparticles for pursuit of selective intracellular doxorubicin release

    X. Yan, Q. Chen, J. An, D. Liu, Y. Huang, R. Yang, W. Li, L. Chen and H. Gao, J. Mater. Chem. B, 2019, Advance Article , DOI: 10.1039/C8TB02370K

Search articles by author

Spotlight

Advertisements